Proteomic and transcriptomic analysis for streptozotocin-induced diabetic rat pancreas in response to fungal polysaccharide treatments

Proteomics

Volumn 8, Issue 11, 2008, Pages 2344-2361

  Sang, Woo Kim ^a   Hye, Jin Hwang ^a   Yu, Mi Baek ^a   Sung, Hak Lee ^a   Hee, Sun Hwang ^a   Jong, Won Yun ^a  

^a Daegu University   (South Korea)

Author keywords

2 D PAGE; Biomarker; Diabetes mellitus; Microarray; Pancreas proteome

Indexed keywords

CARBONYL REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASIDIOMYCETES; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS; PHELLINUS BAUMII; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; STREPTOZOCIN DIABETES; TRANSCRIPTOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; ISLETS OF LANGERHANS; MALE; MAP KINASE SIGNALING SYSTEM; PANCREAS; POLYSACCHARIDES; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; STREPTOZOCIN; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 46049087000     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700779     Document Type: Article

References (96)

1. Ugochukwu, N. H., Babady, N. E., Antihyperglycemic effect of aqueous and ethanolic extracts of Gongronema latifolium leaves on glucose and glycogen metabolism in livers of normal and streptozotocin-induced diabetic rats. Life Sci. 2003, 73, 1925-1938.
2. Kiho, T., Morimoto, H., Sakushima, M., Usui, S., Ukai, S., Polysaccharides in fungi. XXXV. Anti diabetic activity of an acidic polysaccharide from the fruiting bodies of Tremella aurantia. Biol. Pharm. Bull. 1995, 18, 1627-1629.
3. Kiho, T., Yamane, A., Hui, J., Usui, S., Ukai, S., Polysaccharides in fungi. XXXVI. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effect on glucose metabolism in mouse liver. Biol. Pharm. Bull. 1996, 19, 294-296.
4. Zhang, H. N., Lin, Z. B., Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol. Sin. 2004, 25, 191-195.
5. Gray, A. M., Flatt, P. R., Insulin-releasing and insulin-like activity of Agaricus campestes (mushroom). J. Endocrinol. 1998, 157, 259-266.
6. Talpur, N. A., Echard, B. W., Fan, A. Y., Jaffari, O. et al., Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains. Mol. Cell. Biochem. 2002, 237, 129-136.
7. Ewart, R. B., Kornfeld, S., Kipnis, D. M., Effect of lectins on hormone release from isolated rat islets of langerhans. Diabetes 1975, 24, 705-714.
8. Kim, D. H., Yang, B. K., Jeong, S. C, Hur, N. J. et al., A preliminary study on the hypoglycemic effect of the exo-polymers produced by five different medicinal mushrooms. J. Microbiol. Biotechnol. 2001, 11, 167-171.
9. Kim, D. H., Yang, B. K., Jeong, S. C., Park, J. B. et al., Production of a hypoglycemic, extracellular polysaccharide from the submerged culture of the mushroom, Phellinus linteus. Biotechnol. Lett. 2001, 23, 513-517.
10. Jang, B. S., Kim, J. C., Bae, J. S., Rhee, M. H. et al., Extracts of Phellinus gilvus and Phellinus baumii inhibit pulmonary inflammation induced by lipopolysaccharide in rats. Biotechnol. Lett. 2004, 26, 31-33.
11. Shon, M. Y., Kim, T. H., Sung, N. J., Antioxidants and free radial scavenging activity of Phellinus baumii (Phellinus of Hymenochaetaceae) extracts. Food Chem. 2003, 82, 593-597.
12. Hwang, H. J., Kim, S. W., Lim, J. M., Joo, J. H. et al., Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroom Phellinus baumii in streptozotocin-induced diabetic rats. Life Sci. 2005, 76, 3069-3080.
13. Kim, S. W., Hwang, H. J., Kim, H. M., Lee, M. C. et al., Effect of fungal polysaccharides on the modulation of plasma proteins in streptozotocin-induced diabetic rats. Proteomics 2006, 6, 5291-5302.
14. Kim, S. W., Hwang, H. J., Cho, E. J., Oh, J. Y. et al., Time-dependent plasma protein changes in streptozotocin-induced diabetic rats before and after fungal polysaccharide treatments. J. Proteome Res. 2006, 5, 2966-2976.
15. Nepom, B. S., Schwarz, D., Palmer, J. P., Nepom, G. T., Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-cells produce hybrid molecules in DR3/4 heterozygotes. Diabetes 1987, 36, 114-117.
16. Sparre, T., Bergholdt, R., Nerup, J., Pociot, F., Application of genomics and proteomics in Type 1 diabetes pathogenesis research. Expert Rev. Mol. Diagn. 2003, 3, 743-757.
17. Löhr, M., Faissner, R., Proteomics in pancreatic disease. Pancreatology 2004, 4, 67-75.
18. Shen, J., Person, M. D., Zhu, J., Abbruzzese, J. L., Li, D., Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res. 2004, 64, 9018-9026.
19. Nicolls, M. R., D'Antonio, J. M., Huntton, J. C., Gill, R. G. et al., Proteomics as a tool for discovery: Proteins implicated in Alzheimer's disease are highly expressed in normal pancreatic islets. J. Proteome Res. 2003, 2, 199-205.
20. Andersen, H. U., Larsen, P. M., Fey, S. J., Karlsen, A. E. et al., Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1β-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes 1995, 44, 400-407.
21. Collins, H. W., Buettger, C., Matschinsky, F., High-resolution two-dimentional polyacrylamide gel electrophoresis reveals a glucose-response protein of 65 kDa in pancreatic islet cells. Proc. Natl. Acad. Sci. USA 1990, 87, 5494-5498.
22. Lu, Z. H., Hu, L. P., Evers, S., Chen, J., Shen, Y., Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue. Proteomics 2004, 4, 3975-3988.
23. Sanchez, J. C., Converset, V., Nolan, A., Schmid, G. et al., Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57BI/6 lep/lep mice. Mol. Cell. Proteomics 2002, 1, 509-516.
24. Sanchez, J. C., Converset, V., Nolan, A., Schmid, G. et al., Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated protein in lep/lep mice. Proteomics 2003, 3, 1500-1520.
25. Korc, M., Diabetes mellitus in the era of proteomics. Mol. Cell. Proteomics 2003, 2, 399-404.
26. Sharma, A., Chavali, S., Mahajan, A., Tabassum, R. et al., Genetic association, post-translational modification, and protein-protein interactions in type 2 diabetes mellitus. Mol. Cell. Proteomics 2005, 4, 1029-1037.
27. Gerling, I. C., Singh, S., Lenchik, N. I., Marshall, D. R., Wu, J., New data analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes. Mol. Cell. Proteomics 2006, 5, 293-305.
28. Ball, L. E., Berkaw, M. N., Buse, M. G., Identification of the major site of O-linked β-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol. Cell. Proteomics 2006, 5, 313-323.
29. Kodama, S., Toyonaga, T., Kondo, T., Matsumoto, K. et al., Enhanced expression of PDX-1 and Ngn3 by exendin-4 during β-cell regeneration in STZ-treated mice. Biochem. Biophys. Res. Commun. 2005, 327, 1170-1178.
30. Ohno, T., Ishii, C., Kato, N., Ito, Y. et al., Increased expression of a regenerating (reg) gene protein in neonatal rat pancreas treated with streptozotocin. Endocr. J. 1995, 42, 649-653.
31. Takasawa, S., Okamoto, H., Pancreatic β-cell death, regeneration and insulin secretion: Roles of poly(ADP-ribose) polymerase and cyclic ADP-ribose. Int. J. Exp. Diabetes Res. 2002, 3, 79-96.
32. Qiu, L., List, E. O., Kopchick, J. J., Differentially expressed proteins in the pancreas of diet-induced diabetic mice. Mol. Cell. Proteomics 2005, 4, 1311-1318.
33. Mathis, D., Vence, L., Benoist, C., β-cell death during progression to diabetes. Nature 2001, 414, 792-798.
34. Marzo, N., Mora, C., Fabregat, M. E., Martin, J. et al., Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Diabetologia 2004, 47, 686-694.
35. Wong, F. S., Wen, L., Tang, M., Ramanathan, M. et al., Investigation of the role of β-cells in type 1 diabetes in the NOD mouse. Diabetes 2004, 53, 2581-2587.
36. Fathman, C. G., Soares, L., Chan, S. M., Utz, P. J., An array of possibilities for the study of autoimmunity. Nature 2005, 435, 605-611.
37. Buchholz, M., Boeck, W., Fensterer, H., Müller, F. et al., Use of DNA array/microarrays in pancreatic research. Pancreatology 2001, 1, 581-586.
38. Scearce, L. M., Brestelli, J. E., McWeeney, S. K., Lee, C. S. et al. Functional genomics of the endocrine pancreas. The pancreas clone set and panchip, new resources for diabetes research. Diabetes 2002, 51, 1997-2004.
39. Cardozo, A. K., Kruhøffer, M., Leeman, R., Ørntoft, T., Eizirik, D. L., Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 2001, 50, 909-920.
40. Diraison, F., Motakis, E., Parton, L. E., Nason, G. P. et al., Impact of adenoviral transduction with SREBP1c or AMPK on pancreatic islet gene expression profile. Analysis with oligonucleotide microarrays. Diabetes 2004, 53, S84-S91.
41. Devi, S. S., Mehendale, H. M., Microarray analysis of thioacetamide-treated type 1 diabetic rats. Toxicol. Appl. Pharmacol. 2006, 212, 69-78.
42. Mi, H., Lazareva-Ulitsky, B., Loo, R., Kejariwal, A. et al., The PANTHER database of protein families subfamilies, functions and pathways. Nucleic Acids Res. 2005, 33, D284-D288.
43. Goldberg, H. J., Whiteside, C. I., Hart, G. W., Fantus, I. G., Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology 2006, 147, 222-231.
44. Majumdar, G., Harrington, A., Hungerford, J., Martinez-Hernandez, A. et al., Insulin dynamically regulates calmodulin gene expression by sequential o-glycosylation and phosphorylation of sp1 and its subcellular compartmentalization in liver cells. J. Biol. Chem. 2006, 281, 3642-3650.
45. Levi, R., Ben-Dov, I. Z., Lavi-Moshayoff, V., Dinur, M. et al., Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: Correlation with posttranslational modification of the trans acting factor AUF1. J. Am. Soc. Nephrol. 2006, 17, 107-112.
46. International Human Genome Sequencing Consortium, Finishing the euchromatic sequence of the human genome. Nature 2004, 431, 931-945.
47. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
48. Stefano, G. B., Burrill, J. D., Labur, S., Blake, J., Cadet, P., Regulation of various genes in human leukocytes acutely exposed to morphine: Expression microarray analysis. Med. Sci. Monit. 2005, 11, MS35-MS42.
49. Swanston-Flatt, S. K., Day, C., Flatt, P. R., Gould, B. J., Bailey, C. J., Glycemic effects of traditional European plant treatments for diabetes: Studies in normal and streptozotocin diabetic mice. Diabetes Res. 1989, 10, 69-73.
50. Kakkar, R., Mantha, S. V., Radhi, J., Prasad, K., Kalra, J., Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin. Sci. (Lond.) 1998, 94, 623-632.
51. Friesen, N. T., Buchau, A. S., Schott-Ohly, P., Lgssiar, A., Gleichmann, H., Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin. Diabetologia 2004, 47, 676-685.
52. Hausmann, D. H., Porstmann, T., Weber, I., Hausmann, S. et al., Cu/Zn-SOD in human pancreatic tissue and pancreatic juice. Int. J. Pancreatol. 1997, 22, 207-213.
53. Fujii, J., Ikeda, Y., Advances in our understanding of peroxiredoxins, a multifunctional, mammalian redox protein. Redox Rep. 2002, 7, 123-130.
54. Hoffrogge, R., Mikkat, S., Scharf, C., Beyer, S. et al., 2-DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). Proteomics 2006, 6, 1833-1847.
55. Maurer, M. H., Feldmann, R. E., Fütterer, C. D., Butlin, J., Kuschinsky, W., Comprehensive proteome expression profiling of undifferentiated versus differentiated neural stem cells from adult rat hippocampus. Neurochem. Res. 2004, 29, 1129-1144.
56. Jang, J. S., Cho, H. Y., Lee, Y. J., Ha, W. S., Kim, H. W., The differential proteome profile of stomach cancer: Identification of the biomarker candidates. Oncol. Res. 2004, 14, 491-499.
57. Bast, A., Wolf, G., Oberbaumer, I., Walther, R., Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 2002, 45, 867-876.
58. Duan, R. D., Poensgen, J., Wicker, C., Westrom, B., Erlanson-Albertsson, C., Increase in pancreatic lipase and trypsin activity and their mRNA levels in streptozotocin-induced diabetic rats. Dig. Dis. Sci. 1989, 34, 1243-1248.
59. Duan, R. D., Erlanson-Albertsson, C., Pancreatic lipase and colipase activity increase in pancreatic acinar tissue of diabetic rats. Pancreas 1989, 4, 329-334.
60. Duan, R. D., Erlanson-Albertsson, C., The anticoordinate changes of pancreatic lipase and colipase activity to amylase activity induced by adrenalectomy in normal and diabetic rats. Int. J. Pancreatol. 1990, 6, 271-279.
61. Kim, S. K., Cuzzort, L. M., Allen, E. D., Effects of age on diabetes- and insulin-induced changes in pancreatic levels of alpha-amylase and its mRNA. Mech. Ageing Dev. 1991, 58, 151-161.
62. Kurtz, D. M., Tian, L., Gower, B. A., Nagy, T. R. et al., Transgenic studies of fatty acid oxidation gene expression in nonobese diabetic mice. J. Lipid Res. 2000, 41, 2063-2070.
63. Skibowska, A., Raszeja-Specht, A., Szutowicz, A., Platelet function and acetyl-coenzyme A metabolism in type 1 diabetes mellitus. Clin. Chem. Lab. Med. 2003, 41, 1136-1143,
64. Serra, D., Casals, N., Asins, G., Royo, T. et al., Regulation of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase protein by starvation, fat feeding, and diabetes. Arch. Biochem. Biophys. 1993, 307, 40-45.
65. Casals, N., Roca, N., Guerrero, M., Gil-Gomez, G. et al. Regulation of expression of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene. Its role in the control of ketogenesis. Biochem. J. 1992, 283, 261-264.
66. Maser, E., Neuroprotective role for carbonyl reductase? Biochem. Biophys. Res. Commun. 2006, 340, 1019-1022.
67. Bergholdt, R., Nerup, J., Pociot, F., Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes. J. Med. Genet. 2005, 42, 17-25.
68. De Reggi, M., Gharib, B., Protein-X, Pancreatic stone-, Pancreatic thread-, reg-protein, P19, lithostathine, and now what? Characterization, structural analysis and putative function(s) of the major nonenzymatic protein of pancreatic secretions. Curr. Protein Pept. Sci. 2001, 2, 19-42.
69. Anastasi, E., Ponte, E., Gradini, R., Bulotta, A. et al., Expression of Reg and cytokeratin 20 during ductal cell differentiation and proliferation in a mouse model of autoimmune diabetes. Eur. J. Endocrinol. 1999, 141, 644-652.
70. Okamoto, H., The Reg gene family and Reg proteins: With special attention to the regeneration of pancreatic beta-cells. J. Hepatobiliary Pancreat. Surg. 1999, 6, 254-262.
71. Christofilis, M. A., Carrere, J., Atlan-Gepner, C., Zevaco-Mattei, C. et al. Serum reg protein level is not related to the beta cell destruction/regeneration process during early phases of diabetogenesis in type I diabetes. Eur. J. Endocrinol. 1999, 141, 368-373.
72. Ohno, T., Ishii, C., Kato, N., Ito, Y. et al. Increased expression of a regenerating (reg) gene protein in neonatal rat pancreas treated with streptozotocin. Endocr. J. 1995, 42, 649-653.
73. Kowluru, A., Tannous, M., Chen, H. Q., Localization and characterization of the mitochondrial isoform of the nucleoside diphosphates kinase in the pancreatic β-cell: Evidence for its complexation with mitochondrial succinyl-Co A synthetase. Arch. Biochem. Biophys. 2002, 398, 160-169.
74. Kowluru, A., Defective protein histidine phosphorylation in islets from Goto-Kakizaki diabetic rat. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E498-E503.
75. Matsuda, S., Katsumata, R., Okuda, T., Yamamoto, T. et al. Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer. Cancer Res. 2000, 60, 13-17.
76. Herde, P., Blankenfeldt, W., The purification, crystallization and preliminary structural characterization of human MAWDBP, a member of the phenazine biosynthesis-like protein family. Acta Cryst. 2006, F62, 546-549.
77. Solomon, S. S., Buss, N., Shull, J., Monnier, S. et al., Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-α: Analysis of proteins involved in insulin resistance. J. Lab. Clin. Med. 2005, 145, 275-283.
78. Oppermann, U., Carbonyl reductases: The complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology. Ann. Rev. Pharmacol. Toxicol. 2007, 47, 293-322.
79. Forrest, G. L., Bonzalez, B., Carbonyl reductase. Chem. Biol. Interact. 2000, 129, 21-40.
80. Lemieux, N., Malfoy, B., Forrest, G. L., Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells. Genomics 1993, 15, 169-172.
81. Clemmons, D. R., IGF binding proteins and their functions. Mol. Reprod. Dev. 1993, 35, 368-374.
82. Unterman, T. G., Oehler, D. T., Becker, R. E., Identification of a type 1 insulin-like growth factor binding protein (IGFBP) in serum from rats with diabetes mellitus. Biochem. Biophys. Res. Commun. 1989, 163, 882-887.
83. Graubert, M. D., Goldstein, S., Phillips, L. S., Nutrition and somatomedin XXVII. Total and free IGF-1 and IGF binding proteins in rats with streptozotocin-induced diabetes. Diabetes 1991, 40, 959-965.
84. Luo, J., Murphy, L. J., Differential expression of insulin-like growth factor binding proteins in spontaneously diabetic rats. J. Mol. Endocrinol. 1992, 8, 155-163.
85. Unterman, T. G., Jentel, J. J., Oehler, D. T., Lacson, R. G., Hofert, J. F., Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-1 in the adrenalectomized streptozotocin-diabetic rat. Endocrinology 1993, 133, 2531-2539.
86. Baxter, R. C., Circulating binding proteins for the insulin-like growth factors. Trends Endocrinol. Metab. 1993, 4, 91-96.
87. Denver, R. J., Nicoll, C. S., Pancreatic hormones differentially regulate insulin-like growth factor (IGF)-I and IGF binding protein production by primary rat hepatocytes. J. Endocrinol. 1994, 142, 299-310.
88. Hooper, S. B., Bocking, A. D., White, S. E., Fraher, L. J. et al., Catecholamines stimulate the synthesis and release of insulin-like growth factor binding protein-1 (IGFBP-1) by fetal sheep liver in vivo. Endocrinology 1994, 134, 1104-1112.
89. Cordell, B., Bell, G., Tischer, E., DeNoto, F. M. et al. Isolation and characterization of a cloned rat insulin gene. Cell 1979, 18, 533-543.
90. Leroux, L., Desbois, P., Lamotte, L., Duvillié, B. et al., Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 2001, 50, S150-S153.
91. Duvillié, B., Currie, C., Chrones, T., Bucchini, D. et al., Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to β-cell hyperplasia in mutant mice lacking insulin. Endocrinology 2002, 143, 1530-1537.
92. Jarabak, J., Harvey, R. G., Studies on three reductases which have polycyclic aromatic hydrocarbon quinones as substreates. Arch. Biochem. Biophys. 1993, 303, 394-401.
93. Storz, P., Reactive oxygen species-mediated mitochondria-to-nucleus signaling: A key to aging and radical-caused disease. Sci. STKE 2006, 2006, re3.
94. White, M. F., IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 2002, 283, E413-E422.
95. Baxter, R. C., Insulin-like growth factor binding proteins as glucoregulators. Metabolism 1995, 44, 12-17.
96. Spagnoli, A., Rosenfeld, R. G., Insulin-like growth factor binding proteins. Curr. Opin. Endocinol. Diabetes 1997, 4, 1-9.